• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

在一名患有同种异体移植血管病变的心脏移植患者中，使用药物洗脱支架治疗无保护左主干冠状动脉狭窄。

Treatment of unprotected left main coronary artery stenosis with a drug eluting stent in a heart transplant patient with allograft vasculopathy.

作者信息

Matos G, Steen L, Leya F

机构信息

Department of Cardiology, Loyola University Medical Center, 2130 South First Avenue, Maywood, IL 60153, USA.

出版信息

Heart. 2005 Feb;91(2):e11. doi: 10.1136/hrt.2004.045096.

DOI:10.1136/hrt.2004.045096
PMID:15657201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1768724/
Abstract

High risk angioplasty with drug eluting stent placement into an unprotected left main coronary artery in a heart transplant recipient with allograft vasculopathy is reported. Ten month angiographic follow up is reported. The literature is reviewed and current methods of revascularisation are described in detail. This is the first report of drug eluting stent use in this clinical situation.

摘要

报道了在一名患有移植血管病变的心脏移植受者中，将药物洗脱支架置入无保护左主干冠状动脉的高风险血管成形术。报告了10个月的血管造影随访情况。对文献进行了综述，并详细描述了当前的血运重建方法。这是关于在这种临床情况下使用药物洗脱支架的首例报告。

相似文献

1
Treatment of unprotected left main coronary artery stenosis with a drug eluting stent in a heart transplant patient with allograft vasculopathy.在一名患有同种异体移植血管病变的心脏移植患者中，使用药物洗脱支架治疗无保护左主干冠状动脉狭窄。
Heart. 2005 Feb;91(2):e11. doi: 10.1136/hrt.2004.045096.
2
Proximal left anterior descending coronary artery revascularization with drug-eluting stents.使用药物洗脱支架对左冠状动脉前降支近端进行血运重建。
Arq Bras Cardiol. 2007 Feb;88(2):159-66. doi: 10.1590/s0066-782x2007000200005.
3
Drug-eluting coronary stents: many meta-analyses, little benefit.药物洗脱冠状动脉支架：众多荟萃分析，获益寥寥。
Prescrire Int. 2009 Apr;18(100):70-4.
4
Trends in percutaneous versus surgical revascularization of unprotected left main coronary stenosis in the drug-eluting stent era: a report from the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR).药物洗脱支架时代非保护左主干冠状动脉狭窄经皮与外科血运重建的趋势：美国心脏病学会-国家心血管数据注册库（ACC-NCDR）的报告
Catheter Cardiovasc Interv. 2006 Dec;68(6):867-72. doi: 10.1002/ccd.20886.
5
Treatment of left anterior descending coronary artery disease with sirolimus-eluting stents.西罗莫司洗脱支架治疗左前降支冠状动脉疾病
Circulation. 2004 Jul 27;110(4):374-9. doi: 10.1161/01.CIR.0000136580.34604.B8. Epub 2004 Jul 12.
6
Comparing long-term outcomes between drug-eluting and bare-metal stents in the treatment of cardiac allograft vasculopathy.比较药物洗脱支架与裸金属支架治疗心脏移植血管病变的长期疗效。
Catheter Cardiovasc Interv. 2009 Oct 1;74(4):543-9. doi: 10.1002/ccd.22058.
7
Left main coronary artery stenosis treatment with two paclitaxel-eluting stents in a patient with cardiac allograft vasculopathy.心脏移植血管病变患者使用两枚紫杉醇洗脱支架治疗左主干冠状动脉狭窄
Arch Cardiol Mex. 2008 Oct-Dec;78(4):407-12.
8
Outcomes of bare metal versus drug-eluting stents in allograft vasculopathy.同种异体移植血管病变中裸金属支架与药物洗脱支架的疗效比较。
J Heart Lung Transplant. 2008 Nov;27(11):1222-8. doi: 10.1016/j.healun.2008.08.005.
9
Clinical and angiographic results of angioplasty with a paclitaxel-eluting stent for unprotected left main coronary artery disease (a study of 101 consecutive patients).使用紫杉醇洗脱支架治疗无保护左主干冠状动脉疾病的临床及血管造影结果（对101例连续患者的研究）
Arch Cardiovasc Dis. 2008 Jan;101(1):11-7. doi: 10.1016/s1875-2136(08)70249-3.
10
Integrated coronary revascularization with drug-eluting stents: immediate and seven-month outcome.药物洗脱支架冠状动脉综合血运重建：即刻及7个月结果
J Thorac Cardiovasc Surg. 2006 May;131(5):956-62. doi: 10.1016/j.jtcvs.2005.10.058. Epub 2006 Apr 27.

本文引用的文献

1
Intracoronary radiation to treat in-stent restenosis in six cardiac transplant patients.冠状动脉内放射治疗六例心脏移植患者的支架内再狭窄。
Catheter Cardiovasc Interv. 2003 Sep;60(1):41-4. doi: 10.1002/ccd.10607.
2
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.经皮冠状动脉介入治疗后早期持续双重口服抗血小板治疗：一项随机对照试验。
JAMA. 2002 Nov 20;288(19):2411-20. doi: 10.1001/jama.288.19.2411.
3
Should we still perform angioplasty and stenting of an unprotected left main coronary artery stenosis in heart transplant patients? Two new cases and a review of the literature.对于心脏移植患者，我们是否仍应进行非保护左主干冠状动脉狭窄的血管成形术和支架置入术？两例新病例及文献综述。
J Heart Lung Transplant. 2001 Nov;20(11):1217-9. doi: 10.1016/s1053-2498(01)00310-2.
4
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study.氯吡格雷与阿司匹林预处理后长期治疗对接受经皮冠状动脉介入治疗患者的影响：PCI-CURE研究
Lancet. 2001 Aug 18;358(9281):527-33. doi: 10.1016/s0140-6736(01)05701-4.
5
Stent placement for non-STRESS/BENESTENT lesions: a critical review.非STRESS/BENESTENT病变的支架置入：一项批判性综述。
Catheter Cardiovasc Interv. 2000 Oct;51(2):223-33. doi: 10.1002/1522-726x(200010)51:2<223::aid-ccd21>3.0.co;2-f.
6
The role of percutaneous transluminal coronary angioplasty in heart transplant recipients.
J Heart Lung Transplant. 2000 Jun;19(6):557-65. doi: 10.1016/s1053-2498(00)00115-7.
7
Coronary angioplasty and stenting in cardiac allograft vasculopathy following heart transplantation.心脏移植后心脏移植血管病变的冠状动脉血管成形术和支架置入术。
Transplant Proc. 2000 Mar;32(2):463-5. doi: 10.1016/s0041-1345(00)00818-6.
8
Stenting of an unprotected left main coronary artery stenosis in a cardiac transplant patient.心脏移植患者无保护左主干冠状动脉狭窄的支架置入术。
Can J Cardiol. 1999 Oct;15(10):1131-5.
9
Catheter-based reperfusion of unprotected left main stenosis during an acute myocardial infarction (the ULTIMA experience). Unprotected Left Main Trunk Intervention Multi-center Assessment.急性心肌梗死期间基于导管的无保护左主干狭窄再灌注（ULTIMA经验）。无保护左主干干预多中心评估。
Am J Cardiol. 1999 Jun 1;83(11):1513-7. doi: 10.1016/s0002-9149(99)00139-3.
10
Initial and long-term results of angioplasty in unprotected left main coronary artery.非保护左主干冠状动脉血管成形术的初始及长期结果
Am J Cardiol. 1999 Jan 1;83(1):32-7. doi: 10.1016/s0002-9149(98)00778-4.